NZ332497A - Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent - Google Patents
Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agentInfo
- Publication number
- NZ332497A NZ332497A NZ332497A NZ33249797A NZ332497A NZ 332497 A NZ332497 A NZ 332497A NZ 332497 A NZ332497 A NZ 332497A NZ 33249797 A NZ33249797 A NZ 33249797A NZ 332497 A NZ332497 A NZ 332497A
- Authority
- NZ
- New Zealand
- Prior art keywords
- solvent
- alkylene glycol
- stiffening agent
- fatty acid
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9601665A SE9601665D0 (sv) | 1996-04-30 | 1996-04-30 | Biologically active composition |
| PCT/SE1997/000721 WO1997040818A1 (en) | 1996-04-30 | 1997-04-29 | Biologically active composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ332497A true NZ332497A (en) | 1999-05-28 |
Family
ID=20402417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ332497A NZ332497A (en) | 1996-04-30 | 1997-04-29 | Pharmaceutical composition having a carrier system containing a combination of an alkylene glycol and unsaturated fatty acid alcohol as the solvent and a stiffening agent |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6979454B1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP0952819B1 (cg-RX-API-DMAC10.html) |
| JP (1) | JP4283892B2 (cg-RX-API-DMAC10.html) |
| AT (1) | ATE345777T1 (cg-RX-API-DMAC10.html) |
| AU (1) | AU701720B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2251702C (cg-RX-API-DMAC10.html) |
| DE (1) | DE69736985T2 (cg-RX-API-DMAC10.html) |
| ES (1) | ES2276425T3 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ332497A (cg-RX-API-DMAC10.html) |
| SE (1) | SE9601665D0 (cg-RX-API-DMAC10.html) |
| WO (1) | WO1997040818A1 (cg-RX-API-DMAC10.html) |
| ZA (1) | ZA973705B (cg-RX-API-DMAC10.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7595378B2 (en) | 2001-06-13 | 2009-09-29 | Genmab A/S | Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| DK1871353T3 (da) * | 2005-04-15 | 2011-04-04 | Einstein Coll Med | Vitamin k til forebyggelse eller behandling af hududslæt sekundært til anti-EGFR-terapi |
| US9428582B2 (en) * | 2006-07-03 | 2016-08-30 | Genmab A/S | Method of treating rash in patients undergoing anti-EGFR therapy |
| ES2550481T3 (es) * | 2007-08-16 | 2015-11-10 | The University Of Chicago | Resistencia a patógenos de plantas |
| US8815953B2 (en) * | 2008-03-13 | 2014-08-26 | Spectrum Pharmaceuticals, Inc. | Formulations of vitamin K analogs for topical use |
| CA2738970A1 (en) * | 2008-10-31 | 2010-05-06 | Moberg Derma Ab | Topical composition comprising a combination of at least two penetration enhancing agents |
| US8968755B2 (en) | 2010-10-23 | 2015-03-03 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
| US8685381B2 (en) | 2010-10-23 | 2014-04-01 | Joel Schlessinger | Topical base and active agent-containing compositions, and methods for improving and treating skin |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4299828A (en) * | 1979-05-31 | 1981-11-10 | E. R. Squibb & Sons, Inc. | Corticosteroid stick formulations |
| US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| DE3446873A1 (de) * | 1984-12-21 | 1986-07-10 | Merckle Gmbh | Fluessige diclofenac-zubereitungen |
| GB8629640D0 (en) * | 1986-12-11 | 1987-01-21 | Beecham Group Plc | Composition & method |
| ATE107517T1 (de) * | 1989-05-25 | 1994-07-15 | Takeda Chemical Industries Ltd | Transdermales therapeutisches mittel. |
-
1996
- 1996-04-30 SE SE9601665A patent/SE9601665D0/xx unknown
-
1997
- 1997-04-29 AU AU27969/97A patent/AU701720B2/en not_active Ceased
- 1997-04-29 ES ES97922252T patent/ES2276425T3/es not_active Expired - Lifetime
- 1997-04-29 CA CA002251702A patent/CA2251702C/en not_active Expired - Fee Related
- 1997-04-29 DE DE69736985T patent/DE69736985T2/de not_active Expired - Lifetime
- 1997-04-29 AT AT97922252T patent/ATE345777T1/de not_active IP Right Cessation
- 1997-04-29 WO PCT/SE1997/000721 patent/WO1997040818A1/en not_active Ceased
- 1997-04-29 ZA ZA9703705A patent/ZA973705B/xx unknown
- 1997-04-29 EP EP97922252A patent/EP0952819B1/en not_active Expired - Lifetime
- 1997-04-29 US US09/155,642 patent/US6979454B1/en not_active Expired - Fee Related
- 1997-04-29 NZ NZ332497A patent/NZ332497A/xx not_active IP Right Cessation
- 1997-04-29 JP JP53881597A patent/JP4283892B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SE9601665D0 (sv) | 1996-04-30 |
| ATE345777T1 (de) | 2006-12-15 |
| CA2251702A1 (en) | 1997-11-06 |
| AU701720B2 (en) | 1999-02-04 |
| AU2796997A (en) | 1997-11-19 |
| ES2276425T3 (es) | 2007-06-16 |
| JP2000509385A (ja) | 2000-07-25 |
| DE69736985T2 (de) | 2007-09-20 |
| CA2251702C (en) | 2007-01-09 |
| ZA973705B (en) | 1997-11-25 |
| JP4283892B2 (ja) | 2009-06-24 |
| US6979454B1 (en) | 2005-12-27 |
| EP0952819B1 (en) | 2006-11-22 |
| WO1997040818A1 (en) | 1997-11-06 |
| EP0952819A1 (en) | 1999-11-03 |
| DE69736985D1 (de) | 2007-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU747041B2 (en) | Penetration enhancing and irritation reducing systems | |
| RU2134101C1 (ru) | Стабильные местнодействующие ретиноидные композиции | |
| US6565879B1 (en) | Topical and transdermal administration of peptidyl drugs with hydroxide-releasing agents as skin permeation enhancers | |
| NZ330369A (en) | aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester | |
| BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
| US4293565A (en) | Transdermal medication system for isosorbide dinitrate | |
| HUP9802861A2 (hu) | Calendula glikozidok alkalmazása bőrsejtek túlburjánzásával kapcsolatos betegségek, így psoriasis kezelésére alkalmas gyógyászati készítmény előállítására, ezen vegyületek, valamint ezeket tartalmazó gyógyászati készítmények | |
| ZA973705B (en) | Biologically active composition. | |
| WO1996020712A1 (en) | Clear non-alcoholic hydrocortisone solutions | |
| ATE147623T1 (de) | Arzneizubereitung zum herstellen eines stabilisierten pulvers das eine kombination aus acetylsalicylsäure und metoclopramid als wirkstoff enthält | |
| PT1305057E (pt) | Composicao de biomateria microparticular para uso medicinal | |
| JP2540294B2 (ja) | 経皮吸収製剤 | |
| US5800831A (en) | Psoriasis treatment with polymer film | |
| JPS60208905A (ja) | ヘヤ−トニツク | |
| ATE91079T1 (de) | Salicylsaeurehaltiges mittel gegen schuppende hauterkrankungen. | |
| DE69803772D1 (de) | Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung | |
| US6113893A (en) | Psoriasis treatment | |
| BG105093A (bg) | Фармацевтичен състав на база на еритромицинови соли на мастни киселини за топично третиране на кожни заболявания | |
| JPS59148717A (ja) | 膣投与製剤 | |
| MXPA00004513A (en) | Penetration enhancing and irritation reducing systems | |
| SI9200262B (sl) | Penetracijo pospešujoča snov |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) | ||
| EXPY | Patent expired |